The AstraZeneca and Johnson & Johnson experimental adenovirus COVID shots appear to be far more deadly to younger and middle-aged people, people compared to the mRNA shots from Pfizer and Moderna.

More details about adenovirus COVID vaccine deaths have been recently reported by Health Impact News which indicates victims of the vaccine range from 27 to 55 years old, and most of them suffer from blood clots.

Australian Genene Norris, 48, and Canadian Francine Boyer, 54 both died a few days after having the COVID-19 vaccine from AstraZeneca.

Boyer was plagued by exhaustion and crippling headaches. She went to the nearest hospital, but doctors could not find out what was wrong with her. She was then transferred to the Montreal Neurological Institute Hospital, where she was diagnosed with cerebral thrombosis or blood clots to the brain. She passed away on April 23.

Meanwhile, Norris became ill almost immediately after receiving the AstraZeneca vaccine. Four days after the vaccination, doctors diagnosed her with “rare” blood clots and hooked her up to dialysis in ICU, as she began to suffer from kidney failure. On April 14, she passed away.

Another reported case was  Jack Last, a 27-year-old British engineer who also died after receiving the AstraZeneca experimental vaccine.

According to The Sun U.K., Last got the  AstraZeneca viral vector shot on March 30. Following that, he experienced excruciating headaches, prompting him to visit West Suffolk Hospital’s A&E department on April 9. His health deteriorated, causing doctors to move him to Cambridge’s Addenbrooke Hospital. However, there was little that could be done to save him.

Anne VanGeest, 35, of Ionia, died as a result of complications after getting the Johnson & Johnson coronavirus vaccine, according to her family.

“Acute subarachnoid hemorrhage non-traumatic,” was written on VanGeest’s death certificate.

Although the Australian TGA spokesperson said the blood clots were “likely linked to the vaccine,” Quebec Premier François Legault told state-run CBC/Radio Canada that “we knew there was a once chance in 100,000 this could happen.”

Blood clots are “very rare,” according to the European Medicines Agency.

Canada’s National Director of Public Health Dr. Horacio Arruda and Australia’s Therapeutic Goods Administration agreed that the benefits of AstraZeneca shots outweigh the dangers, as Health Impact News reported.

EudraVigilance, a European database of suspicious drug reaction cases, has reported 8,430 deaths and 354,177 injuries following injections from four experimental CCP Virus vaccines, reports Health Impact News.

In a statement about their database, EudraVigilance said that their report covers data collected through April 24, 2021, for four experimental vaccines currently in use in Europe from Pfizer, AstraZeneca, Moderna, and Johnson & Johnson.

According to EudraVigilance data, 4,524  of the 8,430 deaths were reported following Pfizer vaccine injections and 184,833 of the 354,177 injuries following AstraZeneca vaccine injections.

The following was a rundown of the data through April 24:

  • Total reactions for the experimental mRNA vaccine Tozinameran (code BNT162b2, Comirnaty) from BioNTech/Pfizer: 4,524 deaths and 151,306 injuries.
  • Total reactions for the experimental mRNA vaccine mRNA-1273 (CX-024414) from Moderna: 2,283 deaths and 17,625 injuries.
  • Total reactions for the experimental vaccine AZD1222 (CHADOX1 NCOV-19) from Oxford/AstraZeneca: 1,579 deaths and 184,833 injuries.
  • Total reactions for the experimental COVID-19 vaccine JANSSEN (AD26.COV2.S) from Johnson & Johnson: 44 deaths and 413 injuries.

This data is provided by the European Medicines Agency (EMA), and anybody can check it using the EudraVigilance framework.

The use of AstraZeneca’s experimental CCP Virus shots has been effectively halted in Denmark and Norway

According to a Norwegian Institute of Public Health statement, the AstraZeneca COVID-19 “vaccine” is riskier than the virus itself, particularly for young people.


Sign up to receive our latest news!

By submitting this form, I agree to the terms.